Elevance Health, Inc.
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)
Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –
Elevance Health IBNR + Expected Development on Reported Claims by Quarter
IBNR + Expected Development on Reported Claims — Prior Claim Year (t-1) ($M)
Elevance Health IBNR + Expected Development on Reported Claims: $1,445M in Q3 2026, up 14.9% from a year earlier.
Latest, Q3 2026
1,445
Period ended Sep 30, 2026
Change on a year earlier
+14.9%
1,258 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
15
Documents cited below
Where the Q3 2026 figure comes from
“At September 30, 2026, the total of net incurred but not reported liabilities plus expected development on reported claims was $ 16,192 , $ 1,445 and $ 412 for the claim years 2026, 2025, and 2024 and prior, respectively.”
Source: 10-Q (2026-10-21) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | IBNR + Expected Development on Reported Claims — Prior Claim Year (t-1) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 1,445 | +14.9% | 10-Q (2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 2,419 | +7.7% | 10-Q (2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 4,653 | +16.9% | 10-Q (2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 829 | +4.7% | 10-K (FY2025, 2026-02-06) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,258 | -9.9% | 10-Q (2025-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 2,247 | -4.3% | 10-Q (2025-07-17) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,979 | -8.0% | 10-Q (2025-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 792 | -6.0% | 10-K (FY2024, 2025-02-20) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,396 | -1.8% | 10-Q (2024-10-17) ↗ |
| Q2 2024 | Jun 30, 2024 | 2,349 | +5.6% | 10-Q (2024-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 4,323 | +7.1% | 10-Q (2024-04-18) ↗ |
| Q4 2023 | Dec 31, 2023 | 843 | – | 10-K (FY2023, 2024-02-21) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,421 | – | 10-Q (2023-10-18) ↗ |
| Q2 2023 | Jun 30, 2023 | 2,224 | – | 10-Q (2023-07-19) ↗ |
| Q1 2023 | Mar 31, 2023 | 4,036 | – | 10-Q (2023-04-19) ↗ |
Cite this data
StockData. (2026). Elevance Health IBNR + Expected Development on Reported Claims ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/mcp-ibnr-prior-claim-year
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.